This article discusses the gender imbalance in the biotech industry. Judy Lieberman (Boston Children’s) is quoted.
Reliable markers could eliminate surgery and radiation therapy for many women diagnosed with a type of cancer that often does not progress beyond its noninvasive form. Andrew Beck (Beth Israel Deaconess) is quoted.
Tapping a chemical we already make could enhance T-cell production
